CHAPLE disease

Also known as: CD55-deficient Protein-losing Enteropathy / CD55-deficient Protein-losing Enteropathy (PLE) / CHAPLE syndrome / Complement hyperactivation, angiopathic thrombosis, protein losing enteropathy syndrome (disorder)

Drug	Drug Name	Drug Description
DB15218	Pozelimab	A human monoclonal IgG4 antibody used to treat CD55-deficient protein-losing enteropathy (PLE) or CHAPLE disease

Drug	Drug Name	Target	Type
DB15218	Pozelimab	Complement C5	target

Drug	Drug Name	Phase	Status	Count
DB15218	Pozelimab	2 / 3	Active Not Recruiting	1
DB15218	Pozelimab	Not Available	Available	1